{"id":1546,"date":"2015-08-13T19:33:25","date_gmt":"2015-08-13T19:33:25","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=1546"},"modified":"2015-08-13T19:33:25","modified_gmt":"2015-08-13T19:33:25","slug":"for-solving-the-backlog-of-drug-registration-cfda-asks-for-opinions","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2015\/08\/13\/for-solving-the-backlog-of-drug-registration-cfda-asks-for-opinions\/","title":{"rendered":"For solving the backlog of drug registration, CFDA asks for opinions"},"content":{"rendered":"

After the State Council required rectifying and reforming the examination and approval of drugs, CFDA asks for advices to solve the backlog problem of drug registration, aiming to increase the efficiency of drug examination and approval, and solve the backlog problem of drug registration. There are several characters: To increase the efficiency of examination and approval, the drug which is not as effective as the brand-name drug shall be not approved; Enterprises are allowed to withdraw applications; Applications in mismatch conditions will be returned; Applicants will be guided to apply \u00a0logically with humanized suggestions; Bioequivalence tests will be switched to filling system from examination and approval system; The examination and approval system of the drug delivery route and the change of variations will be strictly controlled, except the drugs for children; The punishment of fraud \u00a0is emphasized; the examination and approval for drugs which are needed urgently by clinic will be accelerated; the backlog will be examined intensively. (Source: Chinamsr)<\/strong><\/p>\n

CFDA\u4e3a\u89e3\u51b3\u836f\u54c1\u6ce8\u518c\u79ef\u538b\u5f81\u6c42\u610f\u89c1\uff0c\u513f\u7ae5\u836f\u4f01\u53d7\u76ca\u663e\u8457<\/h3>\n

\u6765\u6e90\uff1a\u4e2d\u56fd\u533b\u836f\u8054\u76df<\/a> 2015-08-04<\/p>\n

\u6838\u5fc3\u63d0\u793a\uff1a\u56fd\u52a1\u9662\u8981\u6c42\u5bf9\u836f\u54c1\u5ba1\u8bc4\u5ba1\u6279\u8fdb\u884c\u6574\u6539\u4e4b\u540e\uff0c\u836f\u76d1\u603b\u5c40\u5f88\u5feb\u51fa\u53f0\u4e86\u300a\u5173\u4e8e\u5f81\u6c42\u52a0\u5feb\u89e3\u51b3\u836f\u54c1\u6ce8\u518c\u7533\u8bf7\u79ef\u538b\u95ee\u9898\u7684\u82e5\u5e72\u653f\u7b56\u610f\u89c1\u300b\uff0c\u65e8\u5728\u63d0\u9ad8\u836f\u54c1\u5ba1\u8bc4\u5ba1\u6279\u6548\u7387\uff0c\u89e3\u51b3\u836f\u54c1\u6ce8\u518c\u7533\u8bf7\u79ef\u538b\u7684\u77db\u76fe\u3002\u300a\u5f81\u6c42\u610f\u89c1\u300b\u4e2d\u6709\u51e0\u5927\u7279\u70b9\uff1a\u63d0\u9ad8\u5ba1\u6279\u6807\u51c6\uff0c\u6ca1\u6709\u8fbe\u5230\u4e0e\u539f\u7814\u836f\u8d28\u91cf\u548c\u7597\u6548\u4e00\u81f4\u7684\u4e0d\u4e88\u6279\u51c6\uff0c\u5141\u8bb8\u4f01\u4e1a\u9009\u62e9\u64a4\u56de\uff0c\u9000\u56de\u4e0d\u7b26\u5408\u6761\u4ef6\u7684\u7533\u8bf7\uff0c\u5f15\u5bfc\u7533\u62a5\u4eba\u7406\u6027\u7533\u62a5\uff0c\u6bd4\u4ee5\u5f80\u7684\u610f\u89c1\u66f4\u4eba\u6027\u5316;\u751f\u7269\u7b49\u6548\u6027\u8bd5\u9a8c\u7531\u5ba1\u6279\u5236\u6539\u4e3a\u5907\u6848\u5236;\u4e25\u683c\u63a7\u5236\u6539\u53d8\u5242\u578b\u53ca\u7ed9\u836f\u9014\u5f84\u7684\u5ba1\u8bc4\u5ba1\u6279\uff0c\u513f\u7ae5\u836f\u9664\u5916;\u5f3a\u8c03\u9020\u5047\u884c\u4e3a\u5c06\u4e25\u60e9;\u513f\u7ae5\u7528\u836f\u7b49\u4e34\u5e8a\u6025\u9700\u836f\u54c1\u52a0\u5feb\u5ba1\u6279;\u96c6\u4e2d\u5ba1\u8bc4\u79ef\u538b\u7684\u6ce8\u518c\u5ba1\u6279\u7b49\u3002<\/p>\n

[hide for= “!logged”]<\/p>\n

\u56fd\u52a1\u9662\u8981\u6c42\u5bf9\u836f\u54c1\u5ba1\u8bc4\u5ba1\u6279\u8fdb\u884c\u6574\u6539\u4e4b\u540e\uff0c\u836f\u76d1\u603b\u5c40\u5f88\u5feb\u51fa\u53f0\u4e86\u300a\u5173\u4e8e\u5f81\u6c42\u52a0\u5feb\u89e3\u51b3\u836f\u54c1\u6ce8\u518c\u7533\u8bf7\u79ef\u538b\u95ee\u9898\u7684\u82e5\u5e72\u653f\u7b56\u610f\u89c1\u300b\uff0c\u65e8\u5728\u63d0\u9ad8\u836f\u54c1\u5ba1\u8bc4\u5ba1\u6279\u6548\u7387\uff0c\u89e3\u51b3\u836f\u54c1\u6ce8\u518c\u7533\u8bf7\u79ef\u538b\u7684\u77db\u76fe\u3002\u4e00\u4f4d\u533b\u836f\u884c\u4e1a\u7814\u7a76\u5458\u8868\u793a\uff0c\u6b64\u6b21\u5341\u6761\u5f81\u6c42\u610f\u89c1\u6709\u671b\u4e3a\u513f\u7ae5\u836f\u4f01\u3001\u533b\u836fCRO\u9f99\u5934\u4f01\u4e1a\u7b49\u5e26\u6765\u5229\u597d\u3002<\/p>\n

\u300a\u5f81\u6c42\u610f\u89c1\u300b\u4e2d\u6709\u51e0\u5927\u7279\u70b9\uff1a\u63d0\u9ad8\u5ba1\u6279\u6807\u51c6\uff0c\u6ca1\u6709\u8fbe\u5230\u4e0e\u539f\u7814\u836f\u8d28\u91cf\u548c\u7597\u6548\u4e00\u81f4\u7684\u4e0d\u4e88\u6279\u51c6\uff0c\u5141\u8bb8\u4f01\u4e1a\u9009\u62e9\u64a4\u56de\uff0c\u9000\u56de\u4e0d\u7b26\u5408\u6761\u4ef6\u7684\u7533\u8bf7\uff0c\u5f15\u5bfc\u7533\u62a5\u4eba\u7406\u6027\u7533\u62a5\uff0c\u6bd4\u4ee5\u5f80\u7684\u610f\u89c1\u66f4\u4eba\u6027\u5316;\u751f\u7269\u7b49\u6548\u6027\u8bd5\u9a8c\u7531\u5ba1\u6279\u5236\u6539\u4e3a\u5907\u6848\u5236;\u4e25\u683c\u63a7\u5236\u6539\u53d8\u5242\u578b\u53ca\u7ed9\u836f\u9014\u5f84\u7684\u5ba1\u8bc4\u5ba1\u6279\uff0c\u513f\u7ae5\u836f\u9664\u5916;\u5f3a\u8c03\u9020\u5047\u884c\u4e3a\u5c06\u4e25\u60e9;\u513f\u7ae5\u7528\u836f\u7b49\u4e34\u5e8a\u6025\u9700\u836f\u54c1\u52a0\u5feb\u5ba1\u6279;\u96c6\u4e2d\u5ba1\u8bc4\u79ef\u538b\u7684\u6ce8\u518c\u5ba1\u6279\u7b49\u3002<\/p>\n

\u4e0d\u4e45\u4e4b\u524d\uff0cCFDA\u4ee5\u96f7\u9706\u624b\u6bb5\u8981\u6c42\u5404\u836f\u4f01\u5bf9\u5176\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u8fdb\u884c\u9650\u65f6\u81ea\u67e5\uff0c\u80cc\u540e\u7684\u63a8\u52a8\u529b\u91cf\u6b63\u662f\u56fd\u52a1\u9662\u53d1\u8bdd\u8981\u6c42\u6574\u6539\u836f\u54c1\u5ba1\u8bc4\u3002\u6b64\u6b21\u5f81\u6c42\u610f\u89c1\u7684\u51fa\u53f0\uff0c\u4e5f\u4f7f\u5f97\u8fd9\u4e00\u4e8b\u4ef6\u7684\u540e\u7eed\u53d1\u5c55\u8109\u7edc\u66f4\u52a0\u6e05\u6670\uff0c\u90a3\u5c31\u662f\u5728\u6e05\u7406\u79ef\u538b\u5b58\u91cf\uff0c\u9000\u5ba1\u4e00\u6279\u836f\u54c1\u4e4b\u540e\uff0c\u63d0\u9ad8\u4eff\u5236\u836f\u95e8\u69db\uff0c\u52a0\u5feb\u81ea\u4e3b\u521b\u65b0\u548c\u4e34\u5e8a\u6025\u9700\u7684\u54c1\u79cd\u7684\u5ba1\u8bc4\u3002<\/p>\n

\u4e0a\u8ff0\u7814\u7a76\u5458\u79f0\uff0c\u4ece\u300a\u5f81\u6c42\u610f\u89c1\u300b\u4e0d\u96be\u770b\u51fa\uff0c\u513f\u7ae5\u836f\u4f01\u662f\u6700\u660e\u663e\u7684\u53d7\u76ca\u8005\u3002\u9f13\u52b1\u6539\u53d8\u4e3a\u513f\u7ae5\u836f\u5242\u578b\uff0c\u513f\u7ae5\u7528\u836f\u5b9e\u884c\u5355\u72ec\u6392\u961f\u3001\u52a0\u5feb\u5ba1\u8bc4\u5ba1\u6279\uff0c\u90fd\u5c06\u523a\u6fc0\u513f\u7ae5\u7528\u836f\u4f01\u4e1a\u7814\u53d1\u79ef\u6781\u6027\uff0c\u4fc3\u8fdb\u513f\u7ae5\u7528\u836f\u7814\u53d1\u5c06\u5728\u6570\u91cf\u548c\u901f\u5ea6\u65b9\u9762\u7684\u63d0\u5347\u3002\u5eb7\u829d\u836f\u4e1a(300086.SZ)\u3001\u5c71\u5927\u534e\u7279(000915.SZ)\u3001\u8475\u82b1\u836f\u4e1a(002737.SZ)\u3001\u4e9a\u5b9d\u836f\u4e1a(600351.SH)\u3001\u6d4e\u5ddd\u836f\u4e1a(600566.SH)\u3001\u5065\u6c11\u96c6\u56e2(600976.SH)\u7b49\u513f\u7ae5\u7528\u836f\u76f8\u5173\u4f01\u4e1a\u6216\u5c06\u53d7\u76ca\u3002<\/p>\n

CFDA\u8fd9\u4e00\u5f81\u6c42\u610f\u89c1\u51fa\u53f0\u540e\uff0c\u4e5f\u5f15\u8d77\u8d44\u672c\u5e02\u573a\u7684\u5173\u6ce8\uff0c\u591a\u5bb6\u5238\u5546\u5bf9\u6b64\u8fdb\u884c\u70b9\u8bc4\uff0c\u9664\u513f\u7ae5\u836f\u4f01\u4e4b\u5916\uff0c\u4f18\u8d28\u521b\u65b0\u578b\u836f\u4f01\u3001\u4f18\u8d28\u4eff\u5236\u836f\u4f01\u4e1a\u4ee5\u53ca\u533b\u836fCRO\u9f99\u5934\u4f01\u4e1a\u4e5f\u88ab\u8ba4\u4e3a\u8fce\u6765\u91cd\u5927\u5229\u597d\uff0c\u5982\u6052\u745e\u533b\u836f(600276.SH)\u3001\u590d\u661f\u533b\u836f(600196.SH)\u3001\u534e\u6d77\u836f\u4e1a(600521.SH)\u3001\u6d77\u601d\u79d1(002653.SZ)\u3001\u6cf0\u683c\u533b\u836f(300347.SZ)\u3001\u535a\u6d4e\u836f\u4e1a(300404.SZ)\u7b49\u3002<\/p>\n

[\/hide]<\/p>\n","protected":false},"excerpt":{"rendered":"

After the State Council required rectifying and reforming the examination and approval of drugs, CFDA asks for advices to solve the backlog problem of drug registration, aiming to increase the […]<\/p>\n","protected":false},"author":1001,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[5],"tags":[17,23],"class_list":["post-1546","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-company-news","tag-government-supervision","tag-medication"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/1001"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=1546"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1546\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=1546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=1546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=1546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}